ArticleNeoplasia (New York, N.Y.)2013

MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients.

Kai Doberstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.